NCT07259798Completed
Histopathological Findings in En-Bloc vs Conventional Transurethral Resection of Bladder Tumors.
Comparison Between En-Bloc Transurethral Resection Versus Conventional Transurethral Resection of Urinary Bladder Tumors From 2 to 6 cm in Size, Histopathological Findings.
Source: ClinicalTrials.gov · Last updated 10 Dec 2025
Brief summary (registry, in English)
This study is designed to determine whether en-bloc TURBT provides superior histopathological quality and clinical outcomes compared to conventional TURBT in medium-sized bladder tumors.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 21 Nov 2025
- Start date
- 1 Aug 2024
- Primary completion date
- 1 Feb 2025
- Lead sponsor
- Ain Shams University
- Diseases
- Bladder cancer
- NCT number
- NCT07259798
What you commit to
- Study type: Interventional
- Participants enrolled: 50
- From 1 Aug 2024 to the primary completion date, 1 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- concomitant urothelial cancer of the upper urinary tract
Other illness
- metastatic bladder cancer
Other
- recurrent bladder tumours.
Who the study is looking for
- Tumor diameter of 2-6 cm
- Patients fit for spinal or general anesthesia
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ain Shams University Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.